• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

坏死性胰腺炎合并侵袭性念珠菌病及念珠菌血症,病因是泛棘白菌素耐药的[具体菌种未给出]。

Necrotizing pancreatitis with invasive candidiasis and candidemia due to and pan-echinocandin-resistant .

作者信息

Rahimli Laman, Salmanton-García Jon, Kasper Philipp, Simon Michaela, Cornely Oliver A, Stemler Jannik

机构信息

Institute of Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University Hospital Cologne, Faculty of Medicine, University of Cologne, Cologne, Germany.

Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf (CIO ABCD) and Excellence Center for Medical Mycology (ECMM), University Hospital Cologne, Faculty of Medicine), University of Cologne, Cologne, Germany.

出版信息

Med Mycol Case Rep. 2024 Feb 20;43:100636. doi: 10.1016/j.mmcr.2024.100636. eCollection 2024 Mar.

DOI:10.1016/j.mmcr.2024.100636
PMID:38435498
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10906506/
Abstract

We report on a 64-year-old man with necrotizing pancreatitis related, invasive candidiasis, and candidemia. Despite a multidisciplinary management including antifungal therapy, endoscopic interventions and surgery, the patients' infection progressed and lead to colon perforation, retroperitoneal abscess formation, and polymicrobial bloodstream infections. Resistance to echinocandins in further complicated the course. This report emphasizes the need for vigilant monitoring and exploring alternative therapeutic approaches for patients in critical conditions.

摘要

我们报告了一名64岁男性,患有坏死性胰腺炎相关的侵袭性念珠菌病和念珠菌血症。尽管采取了包括抗真菌治疗、内镜干预和手术在内的多学科管理措施,但患者的感染仍在进展,导致结肠穿孔、腹膜后脓肿形成和多重微生物血流感染。对棘白菌素耐药进一步使病情复杂化。本报告强调了对危重症患者进行密切监测和探索替代治疗方法的必要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c74f/10906506/c1091eb9f3d7/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c74f/10906506/76e5eacc3ed8/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c74f/10906506/c1091eb9f3d7/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c74f/10906506/76e5eacc3ed8/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c74f/10906506/c1091eb9f3d7/gr2.jpg

相似文献

1
Necrotizing pancreatitis with invasive candidiasis and candidemia due to and pan-echinocandin-resistant .坏死性胰腺炎合并侵袭性念珠菌病及念珠菌血症,病因是泛棘白菌素耐药的[具体菌种未给出]。
Med Mycol Case Rep. 2024 Feb 20;43:100636. doi: 10.1016/j.mmcr.2024.100636. eCollection 2024 Mar.
2
Candida and candidaemia. Susceptibility and epidemiology.念珠菌与念珠菌血症。药敏性与流行病学。
Dan Med J. 2013 Nov;60(11):B4698.
3
Clinical characteristics of the first cases of invasive candidiasis in China due to pan-echinocandin-resistant and isolates with delineation of their resistance mechanisms.中国首例泛棘白菌素耐药侵袭性念珠菌病病例的临床特征及其耐药机制分析
Infect Drug Resist. 2018 Jan 23;11:155-161. doi: 10.2147/IDR.S152785. eCollection 2018.
4
Accuracy of Sensititre YeastOne echinocandins epidemiological cut-off values for identification of FKS mutant Candida albicans and Candida glabrata: a ten year national survey of the Fungal Infection Network of Switzerland (FUNGINOS).Sensititre YeastOne 棘白菌素药敏试验流行病学折点用于鉴定 FKS 突变的白念珠菌和光滑念珠菌的准确性:瑞士真菌感染网络(FUNGINOS)的十年全国调查。
Clin Microbiol Infect. 2018 Nov;24(11):1214.e1-1214.e4. doi: 10.1016/j.cmi.2018.05.012. Epub 2018 Jun 15.
5
Resistance to Echinocandins Complicates a Case of Bloodstream Infection: A Case Report.棘白菌素耐药使一例血流感染病例复杂化:病例报告
J Fungi (Basel). 2021 May 21;7(6):405. doi: 10.3390/jof7060405.
6
FKS mutant Candida glabrata: risk factors and outcomes in patients with candidemia.FKS 突变的光滑念珠菌:菌血症患者的危险因素和结局。
Clin Infect Dis. 2014 Sep 15;59(6):819-25. doi: 10.1093/cid/ciu407. Epub 2014 May 30.
7
Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species.白色念珠菌和非白色念珠菌引起的侵袭性念珠菌病初始治疗抗真菌疗法的药物经济学分析
BMC Infect Dis. 2017 Jul 10;17(1):481. doi: 10.1186/s12879-017-2573-8.
8
Clumping Morphology Influences Virulence Uncoupled from Echinocandin Resistance in Candida glabrata.光滑念珠菌聚集形态影响毒力但与棘白菌素类耐药性无关。
Microbiol Spectr. 2022 Feb 23;10(1):e0183721. doi: 10.1128/spectrum.01837-21. Epub 2022 Feb 2.
9
Candidemia surveillance in Iowa: emergence of echinocandin resistance.爱荷华州念珠菌血症监测:棘白菌素耐药性的出现。
Diagn Microbiol Infect Dis. 2014 Jun;79(2):205-8. doi: 10.1016/j.diagmicrobio.2014.02.016. Epub 2014 Mar 1.
10
Echinocandin Susceptibility Profile of Fluconazole Resistant Candida Species Isolated from Blood Stream Infections.从血流感染中分离出的氟康唑耐药念珠菌属的棘白菌素敏感性概况
Infect Disord Drug Targets. 2016;16(1):63-8. doi: 10.2174/1871526516666151209155447.

引用本文的文献

1
Candidemia: An Update on Epidemiology, Risk Factors, Diagnosis, Susceptibility, and Treatment.念珠菌血症:流行病学、危险因素、诊断、易感性及治疗的最新进展
Pathogens. 2025 Aug 14;14(8):806. doi: 10.3390/pathogens14080806.
2
Breaking down biofilms across critical priority fungal pathogens: proteomics and computational innovation for mechanistic insights and new target discovery.剖析关键优先真菌病原体中的生物膜:用于深入了解机制和发现新靶点的蛋白质组学与计算创新
mBio. 2025 Aug 13;16(8):e0230324. doi: 10.1128/mbio.02303-24. Epub 2025 Jul 22.

本文引用的文献

1
Questioning the 14-day dogma in candidemia treatment duration.质疑念珠菌血症治疗持续时间的 14 天教条。
Mycoses. 2024 Jan;67(1):e13672. doi: 10.1111/myc.13672. Epub 2023 Nov 3.
2
European candidaemia is characterised by notable differential epidemiology and susceptibility pattern: Results from the ECMM Candida III study.欧洲念珠菌血症具有显著的不同流行病学特征和药敏模式:欧洲临床微生物与感染性疾病学会念珠菌III期研究结果
J Infect. 2023 Nov;87(5):428-437. doi: 10.1016/j.jinf.2023.08.001. Epub 2023 Aug 6.
3
Short Course of Antifungal Therapy in Patients With Uncomplicated Bloodstream Infection: Another Case of Less Is More in the Clinical Setting?
非复杂性血流感染患者的短疗程抗真菌治疗:临床环境中“少即是多”的又一案例?
Open Forum Infect Dis. 2022 Dec 8;10(1):ofac656. doi: 10.1093/ofid/ofac656. eCollection 2023 Jan.
4
The current state of laboratory mycology in Asia/Pacific: A survey from the European Confederation of Medical Mycology (ECMM) and International Society for Human and Animal Mycology (ISHAM).亚太地区实验室真菌学的现状:来自欧洲医学真菌学联盟(ECMM)和国际人类与动物真菌学会(ISHAM)的调查。
Int J Antimicrob Agents. 2023 Mar;61(3):106718. doi: 10.1016/j.ijantimicag.2023.106718. Epub 2023 Jan 12.
5
The current state of laboratory mycology and access to antifungal treatment in Europe: a European Confederation of Medical Mycology survey.欧洲实验室真菌学现状及抗真菌治疗可及性:欧洲医学真菌学联合会调查
Lancet Microbe. 2023 Jan;4(1):e47-e56. doi: 10.1016/S2666-5247(22)00261-0. Epub 2022 Dec 1.
6
The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin.抗真菌药物管线上的药物:福沙那韦、依柏西普、奥洛福康唑、泊沙康唑和瑞他康唑。
Drugs. 2021 Oct;81(15):1703-1729. doi: 10.1007/s40265-021-01611-0. Epub 2021 Oct 9.
7
Emergence of resistant in Germany.德国耐药性的出现。
JAC Antimicrob Resist. 2021 Aug 7;3(3):dlab122. doi: 10.1093/jacamr/dlab122. eCollection 2021 Sep.
8
Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Species From 1997-2016.哨兵抗真菌监测项目二十年:1997 - 2016年菌种监测结果
Open Forum Infect Dis. 2019 Mar 15;6(Suppl 1):S79-S94. doi: 10.1093/ofid/ofy358. eCollection 2019 Mar.
9
Spontaneous Mutational Frequency and Mutation Rates Vary by Echinocandin Agent against .棘白菌素类药物对. 的自发突变频率和突变率各不相同。
Antimicrob Agents Chemother. 2018 Dec 21;63(1). doi: 10.1128/AAC.01692-18. Print 2019 Jan.
10
Increased risk of candidemia in patients with necrotising pancreatitis infected with candida species.患有念珠菌感染的坏死性胰腺炎患者发生念珠菌血症的风险增加。
Pancreatology. 2018 Sep;18(6):630-634. doi: 10.1016/j.pan.2018.07.005. Epub 2018 Jul 14.